Virta joined the Unicorn Club on April 19, 2021, after raising a $133 million Series E funding round led by Tiger Global Management, valuing it at $2 billion. Headquartered in San Francisco, California, United States, Virta Health develops and delivers clinically proven therapies that restore metabolic health for patients with chronic diseases such as diabetes.
By combining advanced biochemistry, clinical expertise, data science, and digital tools, Virta enables sustainable disease reversal without the need for medications or surgery. Its model integrates continuous remote care with personalized nutrition and behavioral support to improve long-term health outcomes.
Keep reading to learn how Virta became a $2B pioneer in chronic disease management and digital healthcare.
What Is Virta and What Does It Do?
Founded in 2014, Virta Health offers a digital care platform designed to reverse chronic metabolic conditions, including type 2 diabetes and obesity. Its technology-powered approach uses personalized nutrition, biomarker tracking, and physician-led remote care to deliver clinically measurable results.
The company’s mission is to reverse diabetes in 100 million people by combining continuous remote monitoring, AI-driven insights, and evidence-based medical care. Virta’s outcomes have been validated in multiple clinical studies demonstrating long-term metabolic improvements and medication reduction.
How Much Funding Has Virta Raised?
1. Series E Round
- Amount Raised: $133 million
- Date: April 19, 2021
- Valuation: $2 billion
- Lead Investor: Tiger Global Management
- Purpose: Accelerate clinical research, expand patient programs, and scale digital care infrastructure
2. Earlier Rounds (Seed to Series D)
- Cumulative Funding: ~$269 million
- Key Investors: Redmile Group, Venrock, and others
- Purpose: Develop a clinical platform, expand the care team, and fund R&D in digital therapeutics
Total Funding Raised: ~$402 million
Latest Funding Date: April 19, 2021
Latest Known Valuation: ~$2 billion
Employee Count: 443 (as of December 31, 2023)
Key Investors
1. Tiger Global Management
- Details: Investment firm backing technology and healthcare companies with strong growth potential.
- Focus Areas: Digital health, SaaS, and AI-driven platforms.
2. Redmile Group
- Details: Healthcare-focused investment firm supporting biotech, diagnostics, and digital health startups.
- Focus Areas: Life sciences innovation, precision medicine, and health data analytics.
3. Venrock
- Details: Venture capital firm with a strong focus on healthcare and technology investments.
- Focus Areas: Healthcare IT, therapeutics, and clinical innovation.
Where Is Virta’s Headquarters?
Virta Health is headquartered in San Francisco, California, United States, with teams working across clinical operations, product development, and patient success.
What’s Next for Virta?
Virta plans to expand its reach in metabolic and chronic disease management by integrating AI-driven diagnostics and targeting conditions such as obesity, hypertension, and prediabetes. The company continues to build partnerships with health systems, employers, and insurers to scale up the accessibility of its digital therapeutic model.
As it advances research and technology, Virta aims to redefine chronic care through continuous monitoring, personalized treatment, and measurable health outcomes.
Get Investor & Funding Insights with TexAu
TexAu provides verified investor and funding data for companies like Virta. Discover insights into digital health, chronic disease management, and healthcare technology that are transforming patient outcomes worldwide.
Sign up for Free on TexAu to access real-time investor and funding intelligence.
